Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1238 |
|
| Actual shortage: | 50 (4%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 36 (3%) | |
| Resolved: | 1152 (93%) | |
Discontinuation Reports |
284 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 283 (100%) | |
| Reversed: | 1 (0%) | |
Late reports |
205 (13%) |
|
Overdue reports |
7 (14%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-CELECOXIB | 200MG | CAPSULE | Resolved | 2017-10-12 | 2018-02-22 | 25753 |
| PMS-GABAPENTIN | 400MG | CAPSULE | Resolved | 2017-10-12 | 2018-02-12 | 25773 |
| SOFLAX CAPSULES 100MG | 100MG | CAPSULE | Resolved | 2017-10-12 | 2020-06-08 | 25813 |
| PMS-LITHIUM CARBONATE - CAP 300MG | 300MG | CAPSULE | Resolved | 2017-11-08 | 2018-03-07 | 28591 |
| PMS-ANAGRELIDE | 0.5MG | CAPSULE | Resolved | 2017-12-07 | 2018-08-24 | 32023 |
| PMS-CELECOXIB | 100MG | CAPSULE | Resolved | 2017-12-07 | 2018-02-22 | 32038 |
| PMS-FLUOXETINE - CAP 20MG | 20MG | CAPSULE | Resolved | 2017-12-07 | 2018-02-20 | 32050 |
| PMS-PREGABALIN | 50MG | CAPSULE | Resolved | 2017-12-07 | 2018-01-26 | 32086 |
| PMS-SERTRALINE | 25MG | CAPSULE | Resolved | 2017-12-08 | 2018-04-19 | 32134 |
| PMS-SERTRALINE | 50MG | CAPSULE | Resolved | 2017-12-08 | 2018-04-19 | 32139 |
| PMS-TESTOSTERONE | 40MG | CAPSULE | Resolved | 2017-12-08 | 2018-04-19 | 32163 |
| PMS-CELECOXIB | 200MG | CAPSULE | Resolved | 2018-01-26 | 2018-03-07 | 37244 |
| PMS-DOCUSATE SODIUM | 100MG | CAPSULE | Resolved | 2018-01-26 | 2018-03-07 | 37257 |
| PMS-FLUOXETINE - CAP 20MG | 20MG | CAPSULE | Resolved | 2018-01-26 | 2018-02-20 | 37269 |
| PMS-SERTRALINE | 100MG | CAPSULE | Resolved | 2018-01-26 | 2018-05-18 | 37334 |
| PMS-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2018-02-06 | 2018-04-19 | 38849 |
| PMS-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2018-02-06 | 2022-12-09 | 38866 |
| SOFLAX | 200MG | CAPSULE | Resolved | 2018-02-06 | 2019-03-28 | 38914 |
| PMS-PREGABALIN | 150MG | CAPSULE | Resolved | 2018-02-12 | 2018-04-17 | 39504 |
| PMS-PREGABALIN | 25MG | CAPSULE | Resolved | 2018-02-12 | 2018-04-19 | 39540 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6051 |
| PMS-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6054 |
| PMS-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6057 |
| PMS-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6060 |
| PMS-LISINOPRIL | 20MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6063 |
| PMS-LISINOPRIL | 20MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6066 |
| PMS-LISINOPRIL | 5MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6069 |
| PMS-BISOPROLOL | 10MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6108 |
| PMS-DESMOPRESSIN | 0.1MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6114 |
| EXTRA STRENGTH ALLERGY RELIEF | 10MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6139 |
| PMS-GLYBURIDE | 5MG | TABLET | Discontinued | 2017-05-02 | 2017-05-02 | 8595 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Discontinued | 2017-10-12 | 2017-10-13 | 25692 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Discontinued | 2017-10-12 | 2017-10-13 | 25698 |
| PMS-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-10-12 | 2017-10-12 | 25717 |
| TELMISARTAN-HCTZ | 25MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25720 |
| TELMISARTAN-HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25724 |
| PMS-RALOXIFENE | 60MG | TABLET | Discontinued | 2017-11-17 | 2017-11-17 | 29515 |
| PMS-PROPAFENONE | 150MG | TABLET | Discontinued | 2017-12-07 | 2018-02-21 | 32089 |
| TELMISARTAN | 40MG | TABLET | Discontinued | 2017-12-15 | 2018-02-02 | 33129 |
| PMS-PIOGLITAZONE | 45MG | TABLET | Discontinued | 2018-02-12 | 2018-02-13 | 39531 |